CHESTERBROOK, Pa., Nov. 6, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (AUXL), a fully integrated specialty biopharmaceutical company, today announced financial results for the quarter ending September 30, 2013. The Company also highlighted select commercial, regulatory and clinical development progress in the third quarter of 2013 and updated guidance for full year 2013.
Help employers find you! Check out all the jobs and post your resume.
